United States · FDA National Drug Code directory
Benzonatate
A source-listed medicine record.
Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.
Medicine identity
- Source reference
- 72865-119_f3f6fdbf-2aa1-4ce3-b3aa-abab79b546c1
- Product NDC
- 72865-119
- Form
- CAPSULE
- Composition / generic term
- Benzonatate
- Labeler
- XLCare Pharmaceuticals, Inc.
- Marketing category
- ANDA
- Marketing start / end (source format)
- 20200217
- Source listing expiry
- 20271231
Source-listed ingredients
- BENZONATATE — 200 mg/1
These values do not establish equivalence or a dose recommendation.
Packages
- 100 CAPSULE in 1 BOTTLE (72865-119-01) · 72865-119-01
- 500 CAPSULE in 1 BOTTLE (72865-119-05) · 72865-119-05
- 30 CAPSULE in 1 BOTTLE (72865-119-30) · 72865-119-30
Source and coverage
Open FDA National Drug Code directory →
Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.
Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.
Browse United States records →